Next Article in Journal
Cutaneous Alternariosis Caused by Alternaria infectoria: Three Cases in Kidney Transplant Patients
Previous Article in Journal
B-Mode Ultrasound Imaging, Doppler Imaging, and Real-Time Elastography in Cutaneous Malignant Melanoma and Lymph Node Metastases
Healthcare 2013, 1(1), 96-99; doi:10.3390/healthcare1010096
Case Report

Scalp In-Transit Metastatic Melanoma Treated with Interleukin-2 and Pulsed Dye Laser

Department of Dermatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
* Author to whom correspondence should be addressed.
Received: 20 August 2013 / Revised: 16 October 2013 / Accepted: 21 October 2013 / Published: 25 October 2013
View Full-Text   |   Download PDF [593 KB, uploaded 25 October 2013]   |   Browse Figure


No particular regimen is considered standard therapy for widespread metastatic melanoma, although surgery is the primary choice for regional nodal metastases. Systemic interleukin-2 (IL-2) is an effective immunotherapy for melanoma, but standard doses are associated with severe toxicity. We report a patient who was treated with intralesional low-dose IL-2 and V-beam pulsed dye laser for the treatment of scalp melanoma metastases. This treatment resulted in rapid regression of metastatic tumors with limited adverse effects.
Keywords: interleukin-2; melanoma; pulsed dye laser therapy interleukin-2; melanoma; pulsed dye laser therapy
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote |
MDPI and ACS Style

Wang, M.Z.; Brewer, J.D. Scalp In-Transit Metastatic Melanoma Treated with Interleukin-2 and Pulsed Dye Laser. Healthcare 2013, 1, 96-99.

View more citation formats

Related Articles

Article Metrics


[Return to top]
Healthcare EISSN 2227-9032 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert